Authors:
BARBOUCHE R
FENOUILLET E
PAPANDREOU MJ
KIENY MP
SABATIER JM
Citation: R. Barbouche et al., PROPERTIES OF HIV ENVELOPE EXPRESSED IN THE PRESENCE OF SPC3, AN ENV-DERIVED PEPTIDE DRUG UNDER PHASE-II CLINICAL-TRIALS, The journal of peptide research, 52(4), 1998, pp. 283-288
Citation: R. Barbouche et al., AN ANTI-HIV PEPTIDE CONSTRUCT DERIVED FROM THE CLEAVAGE REGION OF THEENV PRECURSOR ACTS ON ENV FUSOGENICITY THROUGH THE PRESENCE OF A FUNCTIONAL CLEAVAGE SEQUENCE, Virology (New York, N.Y. Print), 247(2), 1998, pp. 137-143
Citation: C. Perrin et al., ROLE OF GP41 GLYCOSYLATION SITES IN THE BIOLOGICAL-ACTIVITY OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ENVELOPE GLYCOPROTEIN, Virology, 242(2), 1998, pp. 338-345
Citation: Mj. Papandreou et E. Fenouillet, EFFECT OF CHANGES IN THE GLYCOSYLATION OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ENVELOPE ON THE IMMUNOREACTIVITY AND SENSITIVITY TO THROMBIN OF ITS 3RD VARIABLE DOMAIN, Virology, 241(1), 1998, pp. 163-167
Authors:
BARBOUCHE R
MARRAKCHI N
MABROUK K
KRIFI MN
VANRIETSCHOTEN J
FENOUILLET E
ELAYEB M
ROCHAT H
Citation: R. Barbouche et al., ANTIPLATELET ACTIVITY OF THE PEPTIDES COMPOSING THE LEBETIN-1 FAMILY,A NEW CLASS OF INHIBITORS OF PLATELET-AGGREGATION, Toxicon (Oxford), 36(12), 1998, pp. 1939-1947
Citation: E. Fenouillet et al., RECOMBINANT HIV ENVELOPE EXPRESSED IN AN ALPHA-GLUCOSIDASE I-DEFICIENT CHO CELL-LINE AND ITS PARENTAL CELL-LINE IN THE PRESENCE OF 1-DEOXYNOJIRIMYCIN IS FUNCTIONAL, Virology, 231(1), 1997, pp. 89-95
Citation: Mj. Papandreou et E. Fenouillet, EFFECT OF VARIOUS GLYCOSIDASE TREATMENTS ON THE RESISTANCE OF THE HIV-1 ENVELOPE TO DEGRADATION, FEBS letters, 406(1-2), 1997, pp. 191-195
Citation: E. Fenouillet et Im. Jones, THE HYPERGLYCOSYLATION OF HIV ENVELOPE - AN OPPORTUNITY TO ALTER VIRUS INFECTIVITY, Perspectives in drug discovery and design, 5, 1996, pp. 203-212
Authors:
SABATIER JM
MABROUK K
MOULARD M
ROCHAT H
VANRIETSCHOTEN J
FENOUILLET E
Citation: Jm. Sabatier et al., ANTI-HIV ACTIVITY OF MULTIBRANCHED PEPTIDE CONSTRUCTS DERIVED EITHER FROM THE CLEAVAGE SEQUENCE OR FROM THE TRANSMEMBRANE DOMAIN (GP41) OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ENVELOPE, Virology, 223(2), 1996, pp. 406-408
Citation: E. Fenouillet et al., BIOLOGICAL PROPERTIES OF RECOMBINANT HIV ENVELOPE SYNTHESIZED IN CHO GLYCOSYLATION-MUTANT CELL-LINES, Virology, 218(1), 1996, pp. 224-231
Authors:
BARBOUCHE R
MARRAKCHI N
MANSUELLE P
KRIFI M
FENOUILLET E
ROCHAT H
ELAYEB M
Citation: R. Barbouche et al., NOVEL ANTIPLATETLET AGGREGATION POLYPEPTIDES FROM VIPERA-LEBETINA VENOM - ISOLATION AND CHARACTERIZATION, FEBS letters, 392(1), 1996, pp. 6-10
Authors:
PAPANDREOU MJ
IDZIOREK T
MIQUELIS R
FENOUILLET E
Citation: Mj. Papandreou et al., GLYCOSYLATION AND STABILITY OF MATURE HIV ENVELOPE GLYCOPROTEIN CONFORMATION UNDER VARIOUS CONDITIONS, FEBS letters, 379(2), 1996, pp. 171-176
Authors:
BENJOUAD A
CHAPUIS F
FENOUILLET E
GLUCKMAN JC
Citation: A. Benjouad et al., MULTIBRANCHED PEPTIDE CONSTRUCTS DERIVED FROM THE V3 LOOP OF ENVELOPEGLYCOPROTEIN GP120 INHIBIT HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION THROUGH INTERACTION WITH CD4, Virology, 206(1), 1995, pp. 457-464
Citation: E. Fenouillet et Im. Jones, THE GLYCOSYLATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 TRANSMEMBRANE GLYCOPROTEIN (GP41) IS IMPORTANT FOR THE EFFICIENT INTRACELLULAR-TRANSPORT OF THE ENVELOPE PRECURSOR GP160, Journal of General Virology, 76, 1995, pp. 1509-1514
Authors:
BASTIANI P
PAPANDREOU MJ
BLANCK O
FENOUILLET E
THIBAULT V
MIQUELIS R
Citation: P. Bastiani et al., ON THE RELATIONSHIP BETWEEN COMPLETION OF N-ACETYLLACTOSAMINE OLIGOSACCHARIDE UNITS AND IODINE CONTENT OF THYROGLOBULIN - A REINVESTIGATION, Endocrinology, 136(10), 1995, pp. 4204-4209
Authors:
FENOUILLET E
BLANES N
BENJOUAD A
GLUCKMAN JC
Citation: E. Fenouillet et al., ANTI-V3 ANTIBODY REACTIVITY CORRELATES WITH CLINICAL STAGE OF HIV-1 INFECTION AND WITH SERUM NEUTRALIZING ACTIVITY, Clinical and experimental immunology, 99(3), 1995, pp. 419-424
Authors:
BENJOUAD A
FENOUILLET E
GLUCKMAN JC
SABATIER JM
Citation: A. Benjouad et al., MULTIBRANCHED PEPTIDE CONSTRUCTS (MBPC) OF THE V3 LOOP OF ENVELOPE GLYCOPROTEIN GP120 INHIBIT HUMAN IMMUNODEFICIENCY VIRUS-INDUCED SYNCYTIUM FORMATION, Antiviral chemistry & chemotherapy, 5(3), 1994, pp. 195-196
Authors:
FENOUILLET E
BLANES N
COUTELLIER A
GLUCKMAN JC
Citation: E. Fenouillet et al., RELATIONSHIP BETWEEN ANTI-24 ANTIBODY-LEVELS AND P24 ANTIGENEMIA IN HIV-INFECTED PATIENTS (VOL 9, PG 1251, 1993), AIDS research and human retroviruses, 10(4), 1994, pp. 431-431
Citation: A. Benjouad et E. Fenouillet, IMMUNE-RESPONSE AGAINST HUMAN-IMMUNODEFIC IENCY-VIRUS ENVELOPE GLYCOPROTEIN - DOES GLYCOSYLATION BEHAVE AS A SHIELD OR AS ACHILLES HEEL, MS. Medecine sciences, 10(5), 1994, pp. 544-550
Authors:
ZAIDES V
YAGELLO M
VESELOVSKAYA T
SCHMITT D
RYKOVA L
FENOUILLET E
GLUCKMAN JC
Citation: V. Zaides et al., EXTENSIVE C-TERMINAL DELETION IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ENV GLYCOPROTEIN ARISING AFTER LONG-TERM CULTURE OF CHRONICALLY INFECTED-CELLS, Journal of General Virology, 75, 1994, pp. 2963-2975
Authors:
BENJOUAD A
MABROUK K
GLUCKMAN JC
FENOUILLET E
Citation: A. Benjouad et al., EFFECT OF SIALIC-ACID REMOVAL ON THE ANTIBODY-RESPONSE TO THE 3RD VARIABLE DOMAIN OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ENVELOPE GLYCOPROTEIN, FEBS letters, 341(2-3), 1994, pp. 244-250
Authors:
TOUBERT A
SCHMITT D
CORDONNIER A
FENOUILLET E
SARAGOSTI S
Citation: A. Toubert et al., A PEPTIDE SUBSTITUTION IN HIV-1 GP120 1ST HYPERVARIABLE DOMAIN ENHANCES ITS IMMUNOGENICITY IN MICE, AIDS research and human retroviruses, 9(8), 1993, pp. 787-793
Authors:
FENOUILLET E
BLANES N
COUTELLIER A
GLUCKMAN JC
Citation: E. Fenouillet et al., RELATIONSHIP BETWEEN ANTI-P24 ANTIBODY-LEVELS AND P24 ANTIGENEMIA IN HIV-INFECTED PATIENTS, AIDS research and human retroviruses, 9(12), 1993, pp. 1251-1255